Related Experiment Video
Updated: Jul 12, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Electrical and Structural Atrial Remodeling Identifies a High-Risk Phenotype in Embolic Stroke of Undetermined Source
Niklas Bach1, Louisa Bauermeister1, Lisann Böhnke1
1Department of Cardiology and Rhythmology, University Hospital St Josef Hospital Bochum, Germany.
Insights
Atrial remodeling in Embolic Stroke of Undetermined Source (ESUS) patients identifies a high-risk subgroup. Assessing electrical and structural atrial changes can predict adverse cardiovascular events in these patients.
Area of Science:
- Cardiology
- Neurology
- Biomedical Engineering
Background:
- Embolic Stroke of Undetermined Source (ESUS) has a high recurrence risk, but standard treatments lack clear superiority.
- Atrial cardiomyopathy, involving electrical and structural atrial changes, may indicate a higher-risk ESUS population.
Purpose of the Study:
- To assess electrical and structural atrial remodeling in ESUS patients.
- To determine the association between atrial remodeling and adverse cardiovascular outcomes.
Main Methods:
- Prospective study of 103 ESUS patients and 123 controls.
- Evaluated NT-proBNP, ECG, and echocardiography.
- Follow-up for at least 12 months for primary composite endpoint.
Main Results:
- ESUS patients showed higher NT-proBNP, more interatrial block, and poorer left atrial function.
- 28% of ESUS patients reached the primary endpoint within a median follow-up of 382 days.
- NT-proBNP, interatrial block, E', left atrial volume index, and left atrial ejection fraction predicted outcomes.
Conclusions:
- Multimodal atrial remodeling assessment identifies high-risk ESUS patients.
- Atrial cardiomyopathy is clinically relevant for predicting adverse events.
- Findings may inform future anticoagulation and rhythm management studies.
Background:
Embolic stroke of undetermined source (ESUS) carries a substantial recurrence risk, yet anticoagulation has not proven superior to antiplatelet therapy in unselected patients. Atrial cardiomyopathy, reflecting electrical and structural atrial remodeling, may identify a high-risk ESUS subgroup.
Objectives:
The purpose of this study was to characterize the extent of electrical and structural atrial remodeling in patients with ESUS and to evaluate its association with adverse cardiovascular outcomes during follow-up.
Methods:
In this prospective single-center study, 103 consecutive ESUS patients and 123 age- and sex-matched controls without known cardiac disease underwent clinical evaluation, NT-proBNP measurement, 12-lead electrocardiogram, and transthoracic echocardiography. Patients were followed for ≥12 months. The primary endpoint was a composite of all-cause death, recurrent stroke, transient ischemic attack, myocardial infarction, or newly diagnosed atrial fibrillation. Independent predictors were determined using multivariable Cox regression.
Results:
ESUS patients exhibited higher NT-proBNP, more frequent advanced interatrial block, and impaired left atrial function compared with controls. Over a median follow-up of 382 days (IQR: 366-697 days), 29 ESUS patients (29/103, 28%) reached the primary endpoint. Independent predictors were NT-proBNP >420 pg/mL, advanced interatrial block, E' ≤9 cm/s, left atrial volume index ≥29 mL/m2, and left atrial ejection fraction <50%. A risk score integrating ≥3 markers identified a subgroup with markedly increased risk, in whom Kaplan-Meier estimated event-free survival at 1 year was approximately 50% (95% CI: 31.6%-68.4%).
Conclusions:
Multimodal assessment of electrical and structural atrial remodeling identifies a subgroup of ESUS patients with an increased risk of adverse events. These findings underscore the potential clinical relevance of atrial cardiomyopathy and may support further evaluation in future rhythm-guided or anticoagulation studies.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Stroke l: Introduction
Dysrhythmias V: Evaluating Dysrhythmias
